Indication
Degenerative Disc Disease
7 clinical trials
9 products
1 drug
Clinical trial
Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block for Pain Management Following Lumbar Spinal Fusion SurgeryStatus: Completed, Estimated PCD: 2023-08-15
Product
Surgical ESPBProduct
US guided ESPBClinical trial
Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Management for Minimally Invasive (MIS) Lumbar Spine SurgeryStatus: Recruiting, Estimated PCD: 2025-01-01
Product
Bupivacaine-EpinephrineDrug
VarlilumabClinical trial
A Phase 2/3 Prospective, Multicentre Randomized, Double-blind Trial, Comparing Intra-discal Allogeneic Adult BM-MSC Therapy and Sham-treated Controls in Subjects With Chronic LBP Due to Lumbar DDD Unresponsive to Conventional TherapyStatus: Active (not recruiting), Estimated PCD: 2022-05-30
Product
Allogenic BM-MSCsClinical trial
Epidural Steroid Injection With Supplemental Oral Eplerenone for Low Back Pain: A Prospective, Double Blind Randomized TrialStatus: Withdrawn, Estimated PCD: 2025-12-01
Product
EplerenoneClinical trial
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control TrialStatus: Recruiting, Estimated PCD: 2023-12-31
Product
Zolpidem TartrateClinical trial
Ultrasound-Guided Modified-Thoracolumbar Interfascial Plane Block and Lumbar Erector Spinae Plane Block for Pain Management Following Lumbar Spinal Instrumentation SurgeryStatus: Withdrawn, Estimated PCD: 2022-12-30
Product
Erector spinae plane blockClinical trial
A Randomized Controlled Trial of the Effect of Liposomal Bupivacaine (Exparel) When Compared to Saline Control in Reducing Opioid Utilization for Pain Management in Postoperative Lumbar Spine Surgeries.Status: Completed, Estimated PCD: 2022-06-13
Product
Liposomal bupivacaine